Insider trade

Hims & Hers Health (HIMS)Chief Legal Officer sold ~$692K

Soleil Boughton, Chief Legal Officer at Hims & Hers Health, sold ~$692K of Hims & Hers Health shares.

~$692K
Approx. value · 25K sh @ $27.55
314K
Holds after · shares reported
Traded
Aug 19, 2026
Filed
Aug 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 18, 2026Insider · 2 peopleInsiders: 2 sales (~$2.8M)
  2. Jun 22, 2026InsiderCFO sold ~$619K of HIMS shares in the open market
  3. Jun 26, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  4. Jul 6, 2026InsiderCFO sold ~$261K of HIMS shares in the open market
  5. Jul 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.”
  6. Jul 17, 2026InsiderCFO sold ~$229K of HIMS shares in the open market
  7. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
  8. Aug 17, 2026InsiderCFO sold ~$262K of HIMS shares in the open market
  9. Aug 18, 2026InsiderDirector sold ~$467K of HIMS shares in the open market
  10. Aug 19, 2026 · this disclosureInsiderOfficer sold ~$692K of HIMS shares in the open market

What came next

  1. Aug 19, 2026InsiderCFO sold ~$148K of HIMS shares in the open market
  2. Sep 2, 2026InsiderOfficer sold ~$98K of HIMS shares in the open market
  3. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$624K)
  4. Sep 16, 2026InsiderOfficer sold ~$174K of HIMS shares in the open market
  5. Sep 17, 2026InsiderCFO sold ~$355K of HIMS shares in the open market
  6. Sep 22, 2026InsiderCFO sold ~$877K of HIMS shares in the open market
  7. Sep 30, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
  8. Oct 1, 2026InsiderCFO sold ~$59K of HIMS shares in the open market
  9. Oct 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the “Company”) as chief accounting officer. On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting officer of the Company, effective October 9, 2026, concurrently with the previously disclosed resignation of Irene Becklund as the Company's principal accounting officer.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Soleil Boughton, Chief Legal Officer

The full history of Soleil Boughton, Chief Legal Officer is on the profile page.

How this filing works

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data